Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$110.94 USD

110.94
7,458,602

+1.05 (0.96%)

Updated Aug 15, 2024 04:00 PM ET

After-Market: $110.95 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (99 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Can Abbott (ABT) Q4 Earnings Ride on Growth in All Lines?

Abbott's (ABT) imminent quarterly results are expected to reflect a solid performance by the Established Pharmaceuticals Division (EPD) business alike the last reported quarter.

Sriparna Ghosal headshot

Diabetes Management Gains FDA Attention: 3 Stocks in Focus

The FDA recently authorized diabetes care companies to start pairing their medical devices for diabetes management, by combining insulin pumps and glucose monitors.

Urmimala Biswas headshot

3 Medical Product Stocks Set to Beat This Earnings Season

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

Abbott (ABT) Reports Next Week: Wall Street Expects Earnings Growth

Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sweta Killa headshot

7 Dividend ETFs That Offer Growth in 2020

In a low interest rate environment, dividend investing has been the hot spot and seems an excellent choice for 2020.

Abbott's Less-Invasive Surgery for Heart Pump Gets FDA Nod

Abbott's (ABT) less invasive approach for heart surgery for its heart pump gets the FDA clearance, thus paving the way for avoiding open heart surgeries.

The Zacks Analyst Blog Highlights: AbbVie, Abbott Labs, Allergan, Johnson & Johnson and Merck

The Zacks Analyst Blog Highlights: AbbVie, Abbott Labs, Allergan, Johnson & Johnson and Merck

The Zacks Analyst Blog Highlights: Facebook, Alibaba, Mastercard, Abbott Laboratories and Philip Morris International

The Zacks Analyst Blog Highlights: Facebook, Alibaba, Mastercard, Abbott Laboratories and Philip Morris International

Christopher Vargas headshot

3 Dividend-Paying Large Cap Pharma Stocks to Consider for 2020

The stock market continued its end of the year rally Friday as the three major indices all hit new intraday highs.

Mark Vickery headshot

Top Stock Reports for Facebook, Alibaba & Mastercard

Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Alibaba Group (BABA) and Mastercard (MA).

Abbott (ABT) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Abbott (ABT) closed at $86.93, marking a -0.15% move from the previous day.

Abbott (ABT) Dips More Than Broader Markets: What You Should Know

Abbott (ABT) closed the most recent trading day at $83.87, moving -1.88% from the previous trading session.

Abbott (ABT) Dips More Than Broader Markets: What You Should Know

Abbott (ABT) closed at $84.51 in the latest trading session, marking a -1.1% move from the prior day.

Trina Mukherjee headshot

Digital Diabetes Management Gains Momentum: 3 Stocks in Focus

With digital diabetes management space rapidly gaining momentum, patients with diabetes can look forward to better and improved outcomes.

The Zacks Analyst Blog Highlights: Abbott, Philip Morris, Lowe's, Equinix and Kinder Morgan

The Zacks Analyst Blog Highlights: Abbott, Philip Morris, Lowe's, Equinix and Kinder Morgan

Mark Vickery headshot

Top Analyst Reports for Abbott, Philip Morris & Lowe's

Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), Philip Morris International (PM) and Lowe's Companies (LOW).

Abbott (ABT) Up 2.1% Since Last Earnings Report: Can It Continue?

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Medical Products' Nov 7 Earnings Roster: ABC, CAH & More

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

3 Medical Product Stocks Likely to Beat This Earnings Season

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

Urmimala Biswas headshot

Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More

Earnings and revenues for the Medical Instruments sector in the third quarter are likely to have declined sequentially. Read to know how a few companies from the sector might have fared in the period.

Medical Products' Oct 30 Earnings Roster: MCK, MASI & More

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have driven the performance of the players in the medical products space this earnings season.

Medical Products' Oct 24 Earnings Roster: BAX, CERN & More

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

Here's Why You Should Hold on to Abbott (ABT) Stock for Now

Investors continue to be optimistic about Abbott's (ABT) performance.

Medical Products' Earnings Roster for Oct 23: TMO, BSX & More

Encouraging growth in the emerging markets despite the ongoing trade tiff is likely to contribute to revenues in the medical products space this earnings season.

Trina Mukherjee headshot

Medical Products Industry Outlook: Prospects Seem Promising

Growth prospects look bright for the Zacks Medical Products industry, thanks to AI, Medical Mechatronics and Robotics and rampant M&As.